Venture startup

Who invested in PathoVax

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$2.8Mraised across 1 round since 2018, from 1 source

Latest round
Venture, $2.8MAug 2018
Investors
3
See who backed them

The rounds

  1. Aug 2018
    Venture$2.8M

    Source recordedSEC filing: $2.8M sold, first sale May 2018

Everyone who backed them

MassChallengeAccelerator1round
43NorthAccelerator1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about PathoVax

Who invested in PathoVax?

PathoVax's investors include National Science Foundation, MassChallenge and 43North.

How much has PathoVax raised?

PathoVax has raised $2.8M across 1 round since 2018.

When did PathoVax last raise?

PathoVax's most recent round was a Venture of $2.8M in Aug 2018.

What was PathoVax's biggest round?

Its most recent round, $2.8M in Aug 2018, is also its largest on record.

Who backed PathoVax first?

PathoVax's first round on record, in Aug 2018, was backed by National Science Foundation, MassChallenge and 43North.

What stage is PathoVax at?

PathoVax's latest named round is a Venture, in Aug 2018.

Companies like PathoVax

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.